Form 4: Twist Bioscience CEO Sells Shares
Insider Transaction (Form 4)
Emily M. Leproust, Chief Executive Officer and a Director of Twist Bioscience Corp, sold 1,687 shares of common stock on September 21, 2026 for $165.49 per share.
Summary
- Open-market sale: disposed of 1,687 Common Stock at $165.49 ($279,183) on September 21, 2026; holds 618,902 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $279,183 of stock on the open market.
Insider Transactions
Emily M. Leproust — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Open-market sale | Common Stock | 1,687 | $165 | $279.2K | 618,902 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Open-market sale (1,687 shares) |
Keywords
insider transaction, Form 4, TWST, Twist Bioscience Corp, bearish, Emily M. Leproust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.